Abstract
5022 Background: OC is the major cause of death due to gynecological malignancies. Its treatment consists in cytoreductive surgery followed by platinum based chemotherapy. The most important prognostic factor for overall and disease free survival is the residual tumor mass after surgery. Aim of our study is to analyze the role of HE4 in predicting surgical outcome. Methods: Between February 2005 and December 2008 302 consecutive patients with epithelial OC were enrolled. Samples were obtained from the European, multicentric prospective project OVCAD. OC patients were eligible if radical cytoreductive surgery was performed and standard chemotherapy with paclitaxel and carboplatin was applied. A prospective intra- and postoperative documentation was used. Plasma and ascites samples were collected before or during surgery. HE4 concentrations were determined using the ELISA technique. Results: Median age at the time of diagnosis was 58 years (range 18-85 years). Most patients presented with advanced stage dis...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
